Novozymes is a global biotechnology company headquartered in Bagsværd outside of Copenhagen, Denmark. The company has operations in a number of countries around the world, including China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. The Novozymes class A share capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation. Class B shares of its stock are listed on the NASDAQ OMX Nordic exchange.
Novozymes is a world leader within research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients.